Formulation and evaluation of 3D-printed dressings loaded with curcumin and levofloxacin for wound healing application
Abstract
Curcumin (CUR), traditionally used for wound healing, is a promising candidate for incorporation into wound dressings. To enhance its antibacterial efficacy, levofloxacin (LEVO), a broad-spectrum antibiotic effective against both gram-positive and gram-negative bacteria, was co-formulated. CUR and LEVO were incorporated into wound dressings using a semi-solid extrusion (SSE) 3D printing technique. The SSE approach minimised potential drug interactions and eliminated the use of organic solvents. Two different polymers, ethyl cellulose (ethocel) and corn protein (zein), were employed as the matrix materials and comparatively evaluated. The physicochemical and mechanical properties of the printed dressings were assessed, along with drug release profile and antimicrobial activity. Ethocel-based wound dressings demonstrated lower elasticity but higher fracture resistance due to superior tensile strength. In vitro release studies showed that the type of polymer (ethocel or zein) did not significantly affect the release profiles of CUR or LEVO. Antimicrobial assays revealed bacterial counts of <1 CFU/mL in all treated groups for ethocel-based wound dressing except the blank, confirming the antibacterial effectiveness of CUR, LEVO, and their combination against Staphylococcus aureus. The ethocel-CUR-LEVO group showed the most favourable wound healing response, characterised by increased epithelialisation, enhanced fibroblast migration, and reduced neovascularisation. These findings…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.